Merck
CN
Search Within

5108-96-3

Applied Filters:
Keyword:'5108-96-3'
Showing 1-1 of 1 result for "5108-96-3" within Papers
Ilana Chefetz et al.
Cell cycle (Georgetown, Tex.), 10(13), 2206-2214 (2011-05-31)
Recurrent ovarian cancer is resistant to conventional chemotherapy. A sub-population of ovarian cancer cells, the epithelial ovarian cancer stem cells (EOC stem cells) have stemness properties, constitutive NFκB activity, and represent the chemoresistant population. Currently, there is no effective treatment
Page 1 of 1